Upstream
Revolutionary Rice: Lab-Grown Meat Made Easy!
🔬 Lab-grown cow cells + 🌾 rice grains = sustainable food ingredient. 🥩 Innovation in cell-based foods! 🍽️ CO2 reduction, affordable alternative, and global benefits. 🌍
Revolutionary Monitoring Tool for Biopharmaceuticals Unveiled
🔬🐹 Researchers at Merck Italy are developing a better Chinese hamster ovary platform for monitoring host cell proteins. 🧪🔬 HCPMonitoring
Breakthrough: Affordable Customised Albumin Revolutionizes Therapeutics
📅 January 22, 2024. Demand for animal-free recombinant albumin has led to high prices, limiting access to affordable vaccines and monoclonal antibodies. New technologies are increasing production and expanding its use beyond therapeutics to skincare. Albumin is widely used in diagnostics, medical devices, and regenerative medicine. Patent protections and limited suppliers have created shortages. Lower quality albumin is affordable but presents manufacturing and regulatory issues. Customised strains of baker's yeast are now enabling the production of high-quality, affordable albumin. This could accelerate research and unleash the full potential of albumin. ✨🧪💉🌿🔬💊📈
Revolutionary Tech Speeds Up Biotech Cell Line Development
🔍 Abzena launches new tech to speed up cell line development in biotech industry. 🚀 HTSP allows rapid generation and evaluation of high-producing cell lines. 💼 Streamlining processes for biopharma companies. 👩🔬💉
Baker’s Yeast Revolutionizes VHH Discovery and Manufacturing
Baker's yeast 🍞 has the potential to transform VHH discovery and manufacture, making therapies more affordable and accessible.
Finnish Company Receives €12m Grant to Revolutionize Protein Production
📢 Finnish Enifer Oy receives €12m grant to build a mycoprotein factory, aiming for sustainable protein production 🍄. FinnishInnovation
Breakthrough: New Cell Type for Better AAV-Based Drugs!
🔬 Researchers are searching for the perfect cell type to produce rAAVs for gene therapies. 🧪 HEK293 and CHO cells are being considered. 🐹💡🌐
AGC Invests $350M+ to Build Mammalian Plant in Japan: Boosting Biopharma Manufacturing
💰 AGC, a Japanese pharmaceutical company, plans to invest over $350 million in a new mammalian cell culture plant in Chiba, Japan. 🏭 This plant will produce cell cultures for biopharmaceutical manufacturing, strengthening AGC's position in the market. 🧪 Construction to be completed by 2022.
Game-changing Solution: Abundant Albumin Opens Doors
📅 December 20, 2023: Abundant albumin offers opportunities for CDMOs! 🧪💼 Break the monopoly, reduce costs, and increase product likelihood! 🚀🔬
Gavi Boosts Vaccine Manufacturing in Africa: A Game-Changer for Health and Economy!
🌍 Gavi, the Vaccine Alliance, is working to improve vaccine manufacturing capabilities in Africa. The initiative aims to establish vaccine manufacturing hubs on the continent to increase its self-sufficiency.💉
